Sign in

Mark Vergnano

Director at WATERS CORP /DE/WATERS CORP /DE/
Board

About Mark Vergnano

Independent director since 2022 (age 67). Former President & CEO of The Chemours Company and long‑tenured DuPont executive with global operations leadership, manufacturing, sales/marketing, and government affairs experience; education includes a BS from University of Connecticut and MBA from Virginia Commonwealth University . Currently serves on Johnson Controls International’s board; prior public board service includes Chemours (2015–2022) .

Past Roles

OrganizationRoleTenureCommittees/Impact
The Chemours CompanyChairman (2021); President & CEO2015–2021Led transformative growth; implemented ambitious growth strategy
DuPontEVP; Group VP, Safety & Protection; VP/GM Nonwovens & Building Innovations; various roles1980–2015Global operations leadership; sales/marketing; government affairs and public policy exposure

External Roles

OrganizationRoleTenureNotes
Johnson Controls International plc (NYSE: JCI)DirectorJul 2016–presentCurrent public company directorship
The Chemours Company (NYSE: CC)Director2015–2022Former public company directorship

Board Governance

  • Committees at Waters: Compensation; Nominating & Corporate Governance (not Chair) .
  • Committee composition and activity: Compensation Committee (Kuebler Chair, Ornskov, Vergnano) met 3x in 2024; Nominating & Corporate Governance (Ornskov Chair, Huang, Knight, Vergnano) met 3x in 2024 .
  • Independence: Board determined all directors except CEO are independent under NYSE standards; Vergnano qualifies as independent .
  • Attendance and engagement: Board met 11x in 2024; all directors attended at least 75% of Board and respective committee meetings; all directors attended the 2024 annual meeting .
  • Stock ownership guidelines: Non‑employee directors must hold ≥5x annual retainer within 5 years; Vergnano has satisfied the guideline .
  • Executive sessions and governance: Regular executive sessions of independent directors; robust governance practices including proxy access, majority voting, ESG oversight .

Fixed Compensation

Component2024 AmountNotes
Fees Earned or Paid in Cash ($)$97,000 Board and committee retainers/meeting fees; standard structure is $70,000 annual cash retainer + $1,500 per Board/committee meeting; Chair retainers: Audit/Comp/NomGov $15,000; S&T $10,000
Total Cash ($)$97,000
Annual Director Equity Grant ($) – Restricted Stock$109,759 Granted Jan 2, 2024; 334 shares at $328.62; vests Jan 2, 2025
Annual Director Equity Grant ($) – Stock Options$109,898 847 options at $328.62; vests Jan 2, 2025; one‑year term on vesting schedule
Total 2024 Director Compensation ($)$316,657 Mix aligned to cash + equity; equity is time‑based

Performance Compensation

Directors do not receive performance‑conditioned equity (e.g., PSUs) at Waters; annual equity is time‑based restricted stock and stock options with one‑year vesting to align interests and support retention .

Equity AwardGrant DateQuantity/TermsGrant‑Date ValueVesting
Restricted StockJan 2, 2024334 shares @ $328.62$109,759 One‑year vest to Jan 2, 2025
Stock OptionsJan 2, 2024847 options; strike $328.62$109,898 One‑year vest to Jan 2, 2025

Structure: 2024 annual director equity approximately $220,000 split 50% restricted stock / 50% stock options; options priced at grant; both vest over one year; change‑in‑control/death acceleration applicable per award agreements .

Other Directorships & Interlocks

  • Current public boards: Johnson Controls International plc (JCI) .
  • Former public boards: The Chemours Company (CC) .
  • Compensation committee interlocks: None in 2024 for Waters’ Compensation Committee members; no insider participation .
  • Related‑party transactions: Policy requires Audit & Finance review; pre‑approved ordinary‑course arm’s‑length dealings noted for companies linked to other directors (Galderma, Avient, Baxter). No disclosure of transactions involving Johnson Controls or Chemours with Waters in 2024 .

Expertise & Qualifications

  • Global operations leadership in chemicals/industrial; manufacturing, sales/marketing; transformation through significant growth periods (Chemours) .
  • Government affairs/public policy exposure from DuPont tenure .
  • Brings sector‑specific leadership and transformation experience to Compensation and Nominating & Corporate Governance committee oversight .

Equity Ownership

Holding TypeAmountNotes
Common Shares Beneficially Owned4,210 shares As of record date context cited in Security Ownership section footnotes
Stock Options Outstanding1,818 options Outstanding as of Dec 31, 2024 across prior director grants
Ownership Guideline StatusSatisfied Meets 5x annual retainer requirement

Governance Assessment

  • Board effectiveness: Active committee service on Compensation and Nominating & Corporate Governance aligns with his executive leadership background; committees met 3x each in 2024; overall board met 11x; attendance thresholds met, indicating engagement .
  • Independence and alignment: Determined independent by Board; complies with robust director stock ownership guidelines; equity compensation is time‑based, avoiding pay‑for‑performance conflicts for directors .
  • Conflicts/related‑party exposure: No reported related‑party transactions involving Vergnano’s external affiliations; Compensation Committee interlocks explicitly none in 2024—a positive governance signal .
  • Shareholder signals: Waters received ~80% support on 2024 Say‑on‑Pay, indicating generally favorable shareholder sentiment toward compensation governance; supports broader board credibility, though not specific to director pay .
  • Risk controls: Hedging/pledging prohibited; insider trading policy enforced; enterprise risk oversight and regular executive sessions strengthen governance posture .

Red flags: None disclosed related to attendance, related‑party transactions, or interlocks for Vergnano in 2024 .